Boston Scientific Q4 misses Wall Street, a laggard in early medtech ...

Jan 13, 2021 · Dive Brief: Boston Scientific's preliminary fourth-quarter sales of about $2.71 billion, a 6.8% decline on a reported basis, missed Wall Street expectations of $2.86 billion, …

8%
OFF

Boston Scientific Q4 Misses Wall Street, A Laggard In Early Medtech ...

2 weeks from now

Jan 13, 2021 · Dive Brief: Boston Scientific's preliminary fourth-quarter sales of about $2.71 billion, a 6.8% decline on a reported basis, missed Wall Street expectations of $2.86 billion, …

medtechdive.com

$2
OFF

Boston Scientific Misses Q4 Street Projections As Revenues Dip

2 weeks from now

Feb 3, 2021 · Home » Boston Scientific misses Q4 Street projections as revenues dip. ... 8¢ behind Wall Street, where analysts were looking for sales of $2.8 billion. ... BSX shares were …

massdevice.com

2%
OFF

Boston Scientific Gets Q4 Boost From Heart, Urology Sales

2 weeks from now

Boston Scientific said net income rebounded in the fourth quarter, supported by higher sales of both cardiovascular and medical/surgical products. The company’s shares rose more than 2% to $47.37 in morning trading. CEO Mike Mahoney, on a conference call, said most of the company’s business units maintained or expanded market share throughout the y...

medtechdive.com

13%
OFF

Boston Scientific: Why This MedTech Giant Isn’t Slowing Down

2 weeks from now

Sep 17, 2024 · Boston Scientific Raises the Bar With Upside Guidance The company expects net sales for the third quarter of 2024 to grow 13% to 15% year over year and adjusted EPS …

nasdaq.com

$1.73
OFF

Boston Scientific Down Despite Street-beating Q4 - MassDevice

2 weeks from now

Feb 2, 2022 · Boston Scientific projects first-quarter adjusted EPS to come between 38¢ and 40¢ — with fiscal year 2022 EPS between $1.73 and $1.79. Wall Street analysts on average …

massdevice.com

8%
OFF

Boston Scientific Misses Targets Despite Earnings Growth, While The …

2 weeks from now

Apr 24, 2019 · The company brought in $2.493 billion in sales, a growth of 4.8% on a reported basis—or 6.3% when excluding currency fluctuations and sales from Boston Scientific’s 2018 …

fiercebiotech.com

$900
OFF

Boston Scientific Surges On $900 Million Takeover Of Bolt Medical …

2 weeks from now

Jan 8, 2025 · Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million. ... Wall Street’s main indices suffered a bloodbath …

yahoo.com

$0.51
OFF

Here's What Wall Street Expects From Boston Scientific's Earnings

2 weeks from now

Jan 30, 2024 · On January 31, Boston Scientific will release earnings for Q4. In terms of EPS, 28 analysts are predicting earnings of $0.513 per share compared to earnings of $0.450 per …

businessinsider.com

FAQs about Boston Scientific Q4 misses Wall Street, a laggard in early medtech ... Coupon?

Is Boston Scientific (BSX) a rare med-tech growth story?

Boston Scientific Standing Apart As A Rare Med-Tech Growth Story Jan. 14, 2025 2:52 PM ETBoston Scientific Corporation (BSX) StockABT, JNJ, MDT1 Like Stephen Simpson 20.14KFollowers Follow Play(14min) Summary ...

Why did Boston Scientific (BSX) shares edge lower in pre-market trading?

Boston Scientific Corporation ( NYSE: BSX) shares edged lower in the pre-market trading Wednesday after reporting Q4 2022 earnings that fell short of the company’s own guidance and Wall Street forecasts. ...

What happened to Boston Scientific stock?

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million. 26,742 people played the daily Crossword recently. Can you solve it faster than others? "Even at my physical just a month prior, the doctor hadn't noticed anything. I'm forever thankful that I mentioned it." ...

What will Medtech do in the third quarter?

Replicating the broader market trend, MedTech or the Zacks-defined Medical Products companies are expected to report collective sales growth in the third quarter. Over the past couple of quarters, the industry has benefited from an increasing rate of hospitalization, leading to growing demand for a broad array of medical devices. ...

How will Boston Scientific (BSX) perform in 2023?

Boston Scientific ( BSX) projects its net sales growth and adjusted earnings per share for 2023 to reach approximately 5% - 7% YoY and $1.86 – $1.93 compared to ~6% YoY and $1.93 in the consensus, respectively. ...

Is Boston Scientific (BSc) a good stock to buy?

For Boston Scientific, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.79%. On the other hand, the stock currently carries a Zacks Rank of #2. ...